{"@id":"https://bioecon.ru/technology/recombinant-proteins-for-dermatology-oncology/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/recombinant-proteins-for-dermatology-oncology/","json":"https://cn.bioecon.ru/api/v1/technology/recombinant-proteins-for-dermatology-oncology/index.json"},"id":"recombinant-proteins-for-dermatology-oncology","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/dyadic-international/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/loopworm/","https://bioecon.ru/companies/spiber-technologies-ab/","https://bioecon.ru/companies/jiangsu-trautec/","https://bioecon.ru/companies/zero-cow-factory/","https://bioecon.ru/companies/isomerase/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/giant-biogene-holding/","https://bioecon.ru/companies/gilead-sciences/"]},"maturity":7,"name":"皮肤修复与肿瘤微环境重塑重组蛋白药物","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"抗水解工程化基质生长因子突变体"},{"n":2,"title":"活性构象稳定型局部透皮凝胶制剂"},{"n":3,"title":"组织修复再生与血管新生确证"},{"n":4,"title":"瘤内致密基质重塑促进药物浸润"}],"summary":"针对局部外用、透皮吸收或瘤内注射量身定制的重组人生长因子、基质细胞蛋白与趋化因子，用于加速重度难愈性创面再上皮化或重塑促炎性肿瘤间质。","url":"/technology/recombinant-proteins-for-dermatology-oncology/","verified":"2026-11-22"}